Carlos Isanta

Carlos Isanta

Auto-generated profile, based on publicly available information

Carlos Isanta

Hospital Provincial de Nuestra Señora de Garcia, Zaragoza, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
FBFrancisco De Asís Bartol-Puyal
Francisco De Asís Bartol-Puyal
CICarlos Isanta
Carlos Isanta
ÓRÓscar Ruiz-Moreno
Óscar Ruiz-Moreno
BABeatriz Abadia
Beatriz Abadia
PCPilar Calvo
Pilar Calvo
LPLuis Pablo
Luis Pablo
Purpose. To compare the macular choroidal thinning between young healthy, aged healthy, young high myopic, and aged type 2 diabetic (T2D) patients using the Early Treatment Diabetic Retinopathy Study (ETDRS) grid and three-dimensional (3D) maps. Methods. A prospective study including 102 eyes of 51 healthy young subjects, 60 eyes of 30 healthy aged subjects, 24 eyes of 12 high myopic patients, and 110 eyes of 55 T2D patients. Choroidal thickness (CT) was examined with swept-source optical coherence tomography Triton DRI (Topcon Corporation, Tokyo, Japan). The choroid was automatically segmented using the software algorithm, and mean CT values of a 6 × 6 mm macular cube were exported. 3D maps were created to represent CT, and its values were compared using the ETDRS grid. Results. Mean age was 27.31 ± 3.95, 66.41 ± 7.54, 27.69 ± 3.89, and 66.48 ± 7.59 years in young healthy, aged healthy, young high myopic, and T2D patients, respectively. CT was not shown to be uniform, as superior and central zones were thicker. All ETDRS sectors were always thicker (p<0.05) in young healthy individuals than in the others. It was found that the choroidal sector which got thinner was inferior in case of age (103.28 μm decrease), inferior-nasal in high myopia (86.19 μm decrease), and temporal in T2D (55.57 μm decrease). In addition, the choroid got thinner in those regions where it was thicker in healthy subjects. Conclusions. 3D maps allow a further comprehension of choroidal changes. The choroidal pattern in young healthy individuals resembles a mountain range; with age, a mountain peak; in high myopia, an inverted gorge; and in aged T2D, gathered hills. Not all choroidal regions are affected in a similar way, as it depends on the pathology. The thicker the zone is in healthy subjects, the thinner it becomes with any pathology.

1 February 2020 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
BABeatriz Abadia
Beatriz Abadia
FBFrancisco De Asís Bartol-Puyal
Francisco De Asís Bartol-Puyal
PCPilar Calvo
Pilar Calvo
GVGuayente Verdes
Guayente Verdes
CICarlos Isanta
Carlos Isanta
LPLuis E. Pablo
Luis E. Pablo

18 November 2020 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
LDLoay Daas
Loay Daas
JLJose Manuel Larrosa
Jose Manuel Larrosa
AGAlicia Gavin
Alicia Gavin
CICarlos Isanta
Carlos Isanta
ALAchim Langenbucher
Achim Langenbucher
Berthold SeitzBerthold Seitz
Berthold Seitz
This clinical investigation compared the clinical performance of two marketed ophthalmic viscoelastic devices (OVDs): the bacterially derived Healon PRO OVD (test) and the animal-derived Healon OVD (control) under normal use conditions during cataract removal and lens implantation. This prospective, multicenter, randomized, parallel, participant/evaluator masked, postmarket investigation enrolled 139 subjects (170 eyes), 116 (143 eyes) of which were treated (73 test; 70 control group). Both test and control OVDs were used, at a minimum, to inflate the anterior chamber and protect the endothelium prior to cataract extraction according to the standard procedure. The surgeon completed a postsurgery OVD clinical performance questionnaire, and intraocular pressure (IOP) was measured before surgery and at the 1 day postoperative visit with Goldmann applanation tonometry. Any IOP measurement of 30 mmHg or higher was considered a “spike” and recorded as a study-specific, serious adverse event. The bacterially derived Healon PRO OVD was found to be statistically noninferior to the overall clinical performance of the animal-derived Healon OVD control; thus, the primary hypothesis was satisfied. There were no statistically significant differences between OVD groups for any of the additional endpoints relating to IOP changes or to safety, thus satisfying additional hypotheses. The Healon PRO OVD showed statistically significant improvements in surgeon ratings for ease of injectability, transparency/visibility, and ease of IOL placement. The safety profile was also similar between OVD groups with regards to serious and/or device-related adverse events, as well as medical and lens findings. The results of this clinical investigation support the safety and effectiveness of the bacterially derived, currently marketed Healon PRO OVD and indicate that the intraocular surgical performance was similar between the two OVDs.

1 January 2019 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
CIC Isanta-Otal
C Isanta-Otal
GLG López-Valverde
G López-Valverde
AOA J Mateo Orobia
A J Mateo Orobia
LPLE Pablo
LE Pablo
We present the case of a 52-year-old woman referred to our service because of extreme ocular surface dryness. The patient showed corneal, conjunctival, and eyelid manifestations of ocular congenital erythropoietic porphyria (CEP). We started treatment with autologous serum, topical steroids, and cyclosporine twice a day, topical retinoids, and intense corneal lubrication. The patient referred significant improvement of ocular bothering and less discomfort since treatment was initiated. We describe the management of the herewith presented case of ocular CEP.